Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
作者： Kerry S. Campbell , Adam D. Cohen , Tatiana Pazina
关键词:
摘要: … NK cells (14, 15), indicating a role for NK cell-mediated suppression of relapse. NK cells can clearly mediate direct cytotoxicity … in NK cells, and ADCP by macrophages (Figure 2), but …
frontiersin.org
doaj.org参考文章(85)
Cinzia Fionda, Maria Pia Abruzzese, Alessandra Zingoni, Francesca Cecere, Elisabetta Vulpis, Giovanna Peruzzi, Alessandra Soriani, Rosa Molfetta, Rossella Paolini, Maria Rosaria Ricciardi, Maria Teresa Petrucci, Angela Santoni, Marco Cippitelli, The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma Oncotarget. ,vol. 6, pp. 23609- 23630 ,(2015) , 10.18632/ONCOTARGET.4603
Kathryn Lagrue, Alex Carisey, David J. Morgan, Rajesh Chopra, Daniel M. Davis, Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds Blood. ,vol. 126, pp. 50- 60 ,(2015) , 10.1182/BLOOD-2015-01-625004
Zhigang Xie, Jayantha Gunaratne, Lip Lee Cheong, Shaw Cheng Liu, Tze Loong Koh, Gaofeng Huang, Walter P. Blackstock, Wee Joo Chng, Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in T(4;14) multiple myeloma. Oncotarget. ,vol. 4, pp. 1008- 1018 ,(2013) , 10.18632/ONCOTARGET.1049
Sina Gordan, Markus Biburger, Falk Nimmerjahn, bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody‐mediated immune activation and repression Immunological Reviews. ,vol. 268, pp. 52- 65 ,(2015) , 10.1111/IMR.12347
Axel Bouchon, Marina Cella, Helen L. Grierson, Jeffrey I. Cohen, Marco Colonna, Cutting Edge: Activation of NK Cell-Mediated Cytotoxicity by a SAP-Independent Receptor of the CD2 Family Journal of Immunology. ,vol. 167, pp. 5517- 5521 ,(2001) , 10.4049/JIMMUNOL.167.10.5517
Kipp Weiskopf, Irving L Weissman, Macrophages are critical effectors of antibody therapies for cancer mAbs. ,vol. 7, pp. 303- 310 ,(2015) , 10.1080/19420862.2015.1011450
Marzia Leidi, Elisa Gotti, Luca Bologna, Elena Miranda, Monica Rimoldi, Antonio Sica, Massimo Roncalli, Giuseppe A. Palumbo, Martino Introna, Josée Golay, M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro Journal of Immunology. ,vol. 182, pp. 4415- 4422 ,(2009) , 10.4049/JIMMUNOL.0713732
Ilaria Tassi, Marco Colonna, The Cytotoxicity Receptor CRACC (CS-1) Recruits EAT-2 and Activates the PI3K and Phospholipase Cγ Signaling Pathways in Human NK Cells Journal of Immunology. ,vol. 175, pp. 7996- 8002 ,(2005) , 10.4049/JIMMUNOL.175.12.7996
Wen-Kai Weng, Ronald Levy, Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma Journal of Clinical Oncology. ,vol. 21, pp. 3940- 3947 ,(2003) , 10.1200/JCO.2003.05.013
Ashley Mentlik James, Adam D. Cohen, Kerry S. Campbell, Combination immune therapies to enhance anti-tumor responses by NK cells Frontiers in Immunology. ,vol. 4, pp. 481- 481 ,(2013) , 10.3389/FIMMU.2013.00481